Why could we see more deal-making at this year's J. P. Morgan Healthcare conference? Why are investors concerned about a slowdown in U.S. biotech innovation? And what are the hosts' New Year's resolutions?
We discuss all that and more on this week's episode of "The Readout LOUD," STAT's biotech podcast. We chat about how pharmaceutical companies are navigating a looming patent cliff. We also talk about yet another obesity startup and a failed study from Google's secretive anti-aging company Calico.
Listen Now
Subscribe to the podcast on Apple Podcasts or Spotify to never miss an episode
Visit the archive to see past episodes
No comments